Drug Profile
Research programme: oncolytic cancer vaccines - Vyriad
Alternative Names: Vesicular stomatitis virus vaccine - Vyriad; VSV-E6/7 - VyriadLatest Information Update: 28 Aug 2020
Price :
$50
*
At a glance
- Originator Omnis Pharma
- Class Cancer vaccines; Oncolytic viruses
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cancer